Table 4.
Pearson’s correlation analyses between log-transformed apoCIIIHDL and clinical and biochemical parameters.
All subjects (n = 239) | CAD (n = 140) | nonCAD (n = 99) | ||||
---|---|---|---|---|---|---|
r | P | r | P | r | P | |
plasma apoCIII (log-transformed) | 0.607 | <0.0001 | 0.688 | <0.0001 | 0.555 | <0.0001 |
TG | −0.025 | 0.705 | 0.103 | 0.234 | −0.064 | 0.542 |
CEC | −0.241 | 0.0002 | −0.158 | 0.068 | −0.247 | 0.018 |
CK | 0.163 | 0.022 | 0.214 | 0.021 | −0.077 | 0.495 |
UA | 0.186 | 0.005 | 0.224 | 0.01 | 0.202 | 0.051 |
HDL-C (log-transformed) | 0.083 | 0.214 | 0.042 | 0.627 | 0.199 | 0.055 |
hsCRP (log-transformed) | 0.041 | 0.547 | −0.097 | 0.273 | 0.158 | 0.135 |
CAD indicates coronary artery disease; apoCIII, apolipoprotein CIII; TG, triglyceride; CEC, cholesterol efflux capacity; CK, Creatine phosphokinase; UA, uric acid; HDL-C, high density lipoprotein-cholesterol; hsCRP, high sensitivity C reactive protein.